Federico Ballabio

9PUBLICATIONS
96CO-AUTHORS
Molecular targetsMedical parasitologyCell development, proliferation and deathSemi- and unsupervised learningAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 20, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Jan 08, 2026
Targeting the histone-fold dimerization interface of oocyst rupture proteins from Plasmodium berghei for antimalarial inhibitor discovery.

Federico Ballabio, Chiara Bertaso, Marta Villa

|Nov 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Sep 29, 2025
Constant-pH Simulation of the Human β2 Adrenergic Receptor Inactivation.

Federico Ballabio, Riccardo Capelli

|Mar 04, 2025
PLUMED Tutorials: A collaborative, community-driven learning ecosystem.

Gareth A Tribello, Massimiliano Bonomi, Giovanni Bussi

|Mar 03, 2025
A conformational fingerprint for amyloidogenic light chains.

Cristina Paissoni, Sarita Puri, Luca Broggini

Pageof 2

Frequent Collaborators

5 joint publications

Carlo Camilloni

3 joint publications

Riccardo Capelli

2 joint publications

Marina Veronesi

2 joint publications

Luca Maria Giovanni Palloni